The Food and Drug Administration (“FDA”) has removed semaglutide from its drug shortage list after the agency determined the current supply of ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

After May 22, compounding pharmacies can no longer make and sell semaglutide injections. They were initially allowed to because the FDA declared a shortage, but that period has ended. At Melrose ...

Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss drugs tirzepatide and semaglutide.

The Food and Drug Administration had determined there is no longer a shortage of drugs like Ozempic and Wegovy, therefore it had set ending dates for the use of the compounded prescriptions made of ...

When pharmaceutical companies can’t keep up with demand for their FDA-approved drugs, compounding ... compounded forms of semaglutide, which require a prescription and usually come premixed ...

The science-backed rise of GLP-1 medications and the role of compounded semaglutide in modern weight management. How Success by Sesame uses a telehealth weight loss program to provide affordable ...

“I am taking compounded semaglutide ... spotlight, compounding drugs is not a new concept. Pharmacies have long dispensed compounded medication to individual patients under a prescription.